PDF Version for Printing
The articles referenced in this Highlights section will be available online in HTML and PDF formats to all interested users at no charge until the next issue of Cancer Epidemiology, Biomarkers & Prevention is published. Click on the article title to view the complete article.
View the Table of Contents for the April 2009 issue of Cancer Epidemiology, Biomarkers & Prevention
Page 1033
Page 1111
Page 1157
Triple-negative breast cancer (TNBC) refers to tumors lacking estrogen receptors, progesterone receptors, and HER2. Unfortunately, the most successful treatments for breast cancer target these three receptors. The etiology of TNBC appears unique from non-TNBC, but few studies have evaluated these etiological differences. Dolle and colleagues evaluated risk factors for TNBC in women under 45, with respect to demographics, reproductive histories and oral contraceptive (OC) use. This study found that OC use ≥ 1 year was associated with increased risk for TNBC but not for non-TNBC and illustrates important differences in the risk of OC use for specific breast cancer subtypes.